AnaptysBio (ANAB) Short Interest Ratio & Short Volume → Look Who Fired the World’s Richest Man (From Banyan Hill Publishing) (Ad) Free ANAB Stock Alerts $25.47 -0.13 (-0.51%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AnaptysBio Short Interest DataCurrent Short Volume4,370,000 sharesPrevious Short Volume4,270,000 sharesChange Vs. Previous Month+2.34%Dollar Volume Sold Short$106.37 millionShort Interest Ratio / Days to Cover12.2Last Record DateApril 30, 2024Outstanding Shares27,320,000 sharesFloat Size24,200,000 sharesShort Percent of Float18.06%Today's Trading Volume184,130 sharesAverage Trading Volume331,019 sharesToday's Volume Vs. Average56% Short Selling AnaptysBio ? Sign up to receive the latest short interest report for AnaptysBio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANAB Short Interest Over TimeANAB Days to Cover Over TimeANAB Percentage of Float Shorted Over Time Ad Paradigm PressBiden to Drop BOMBSHELL June 13th?Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence. AnaptysBio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,370,000 shares $106.37 million +2.3%18.1%12.2 $24.34 4/15/20244,270,000 shares $90.82 million -0.7%18.0%13.2 $21.27 3/31/20244,300,000 shares $96.84 million +3.9%18.2%13.6 $22.52 3/15/20244,140,000 shares $97.08 million -1.4%17.9%14.5 $23.45 2/29/20244,200,000 shares $107.23 million -6.9%18.3%15.9 $25.53 2/15/20244,510,000 shares $102.65 million -11.7%19.6%17.1 $22.76 Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 1/31/20245,110,000 shares $120.60 million +13.1%22.2%19.7 $23.60 1/15/20244,520,000 shares $104.68 million +1.1%19.6%17.8 $23.16 12/31/20234,470,000 shares $95.75 million -0.7%18.7%19.2 $21.42 12/15/20234,500,000 shares $86.58 million -9.5%18.8%18.9 $19.24 11/30/20234,970,000 shares $70.28 million +0.6%20.8%21.4 $14.14 11/15/20234,940,000 shares $71.09 million -2.2%20.7%21.1 $14.39 10/31/20235,050,000 shares $82.37 million +1.8%21.7%20.9 $16.31 10/15/20234,960,000 shares $93.45 million +4.6%21.3%18.8 $18.84 9/30/20234,740,000 shares $85.13 million +1.1%20.4%17.4 $17.96 9/15/20234,690,000 shares $91.46 million +1.1%20.2%18 $19.50 8/31/20234,640,000 shares $91.32 million -1.7%19.4%18.5 $19.68 8/15/20234,720,000 shares $91.43 million +1.3%19.8%20.1 $19.37 7/31/20234,660,000 shares $91.85 million +1.3%19.4%21.1 $19.71 7/15/20234,600,000 shares $84.96 million -0.7%19.2%24.2 $18.47 6/30/20234,630,000 shares $94.17 million -1.7%19.4%23.4 $20.34 6/15/20234,710,000 shares $88.55 million -5.2%19.7%22 $18.80 5/31/20234,970,000 shares $94.93 million +2.5%20.7%24.1 $19.10 5/15/20234,850,000 shares $93.94 million +1.5%20.2%22 $19.37 4/30/20234,780,000 shares $99.52 million +0.4%19.6%21.8 $20.82 4/15/20234,760,000 shares $102.48 million +1.1%18.8%16.6 $21.53 3/31/20234,710,000 shares $102.49 million +2.6%18.5%16.3 $21.76 3/15/20234,590,000 shares $105.43 million +7.2%18.1%15.1 $22.97 2/28/20234,280,000 shares $106.57 million +1.4%16.9%14 $24.90 2/15/20234,220,000 shares $110.48 million +0.5%16.4%13.9 $26.18 1/31/20234,200,000 shares $104.54 million -15.0%16.1%13.7 $24.89 1/15/20234,940,000 shares $130.32 million -8.2%18.9%18.4 $26.38 12/30/20225,380,000 shares $166.73 million -1.5%20.6%23.6 $30.99 12/15/20225,460,000 shares $156.37 million +0.7%20.9%28.3 $28.64 11/30/20225,420,000 shares $149.75 million -2.2%20.7%26.8 $27.63 11/15/20225,540,000 shares $165.98 million -1.6%21.2%23.7 $29.96 10/31/20225,630,000 shares $162.43 million +2.6%21.7%22.1 $28.85 10/15/20225,490,000 shares $145.59 million -1.6%21.1%20.8 $26.52 9/30/20225,580,000 shares $142.35 million +3.1%22.4%20.7 $25.51 9/15/20225,410,000 shares $138.50 million +4.4%21.7%19.6 $25.60Look Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. ANAB Short Interest - Frequently Asked Questions What is AnaptysBio's current short interest? Short interest is the volume of AnaptysBio shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 4,370,000 shares of ANAB short. 18.06% of AnaptysBio's shares are currently sold short. Learn More on AnaptysBio's current short interest. What is a good short interest ratio for AnaptysBio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANAB shares currently have a short interest ratio of 12.0. Learn More on AnaptysBio's short interest ratio. Which institutional investors are shorting AnaptysBio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AnaptysBio: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for AnaptysBio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.06% of AnaptysBio's floating shares are currently sold short. Is AnaptysBio's short interest increasing or decreasing? AnaptysBio saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 4,370,000 shares, an increase of 2.3% from the previous total of 4,270,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is AnaptysBio's float size? AnaptysBio currently has issued a total of 27,320,000 shares. Some of AnaptysBio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AnaptysBio currently has a public float of 24,200,000 shares. How does AnaptysBio's short interest compare to its competitors? 18.06% of AnaptysBio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to AnaptysBio: CureVac (4.79%), Cogent Biosciences, Inc. (12.59%), GH Research PLC (5.05%), Calliditas Therapeutics AB (publ) (0.03%), Wave Life Sciences Ltd. (2.27%), Nuvation Bio Inc. (2.51%), Sage Therapeutics, Inc. (16.60%), Pharming Group (0.01%), Mineralys Therapeutics, Inc. (4.46%), Lyell Immunopharma, Inc. (16.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short AnaptysBio stock? Short selling ANAB is an investing strategy that aims to generate trading profit from AnaptysBio as its price is falling. ANAB shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AnaptysBio? A short squeeze for AnaptysBio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ANAB, which in turn drives the price of the stock up even further. How often is AnaptysBio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANAB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CureVac Short Squeeze Cogent Biosciences Short Squeeze GH Research Short Squeeze Calliditas Therapeutics AB (publ) Short Squeeze Wave Life Sciences Short Squeeze Nuvation Bio Short Squeeze Sage Therapeutics Short Squeeze Pharming Group Short Squeeze Mineralys Therapeutics Short Squeeze Lyell Immunopharma Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANAB) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research